drugset / Trial / NCT02183467
Effect of BI 1356 as Single Dose on the QT Interval in Healthy Female and Male Subjects
RandomizedCrossoverDouble-blindTreatment
Summary
Assessment of the effect of BI 1356 or Placebo on prolongation of the QT interval
Timeline
- Start
- 2008-01
- Primary completion
- 2008-06
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Linagliptin | Unknown | 5 mg | — |
| Subject | Linagliptin | Unknown | 100 mg | — |
| Comparator | Moxifloxacin | Small molecule | — | — |
Indications
No indication recorded.